A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

The first line of management of bladder cancer is the combination of cystoscopy to find papillary lesions or other irregularities, and urine cytology to help identify abnormalities that may not be ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...

James: Adding an MRI post-flexible cystoscopy improved decision-making and accelerated time to correct treatment considerably for the worst muscle-invasive bladder cancer cases, without ...

The cancer’s grade, stage, and response to treatment determine the next steps. In TURBT surgery, a doctor passes a cystoscope through your urethra into your bladder and removes abnormal cells.

Bladder cancer affects approximately 83,000 Americans ... imaging studies like CT urography, and often cystoscopy, a procedure that allows direct visualization of the bladder interior.

Urinary retention is a common condition in men characterised by the inability to fully empty the bladder despite the urge to ...

We know the importance of using Blue Light Cystoscopy in the precision diagnostic pathway for bladder cancer, where accurate staging and resection helps determine the optimal treatment decisions ...

The FDA approved Padcev and Keytruda for advanced bladder cancer in December 2023, following accelerated approval for cisplatin-ineligible patients. Both treatments have lower odds of high-grade side ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Jane Healy as Vice President and General Manager EMEA.